Skip to content

IIH Provoke: headache mechanisms in idiopathic intracranial hypertension

Mechanisms driving headache in idiopathic intracranial hypertension, a human physiology study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13251508
Enrollment
24
Registered
2022-10-24
Start date
2023-02-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic intracranial hypertension Nervous System Diseases

Interventions

IIH Provoke is a prospective, randomised, double-blind, placebo-controlled two-way crossover physiology study. Up to 24 patients with idiopathic intracranial hypertension (IIH) will undergo headache p

Sponsors

University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years old 2. Previous diagnosis of idiopathic intracranial hypertension (IIH) 3. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Aged less than 18 or older than 60 years old 2. Optic nerve elevation exclusively due to pseudopapilloedema 3. Previous migraine history prior to the diagnosis of IIH (or non-IIH headache) > 1 day per month 4. Pregnant or trying to conceive 5. Significant co-morbidity; such that in the opinion of the investigator it would not be in the participant’s best interest to participate in the trial 6. Known cardiovascular or cerebrovascular disease 7. Medication overuse 8. Inability to comply with study schedule or follow-up 9. Currently using Glucagon-like peptide-1 receptor (GLP-1R) agonist or Dipeptidyl-peptidase 4 (DPP-4) inhibitor 10. Contra-indications to undergoing a surgical procedure

Design outcomes

Primary

MeasureTime frame
The following measures were assessed after a single visit: 1. Incidence of provoked headache akin to the participant's typical IIH headache measured using a Headache assessment tool 2. Change in intracranial pressure (ICP) during a headache attack determined using physiological measurement 3. Headache physiological response over the 24 hours post-dose measured using a Headache assessment tool

Secondary

MeasureTime frame
The following measures were assessed after a single visit: 1. Change in headache features measured using a Headache assessment tool and diary 2. Dynamic changes in cerebrovascular physiology and headache biomarkers determined using physiological measurement

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 3, 2026